Get the Stockscreener App
371.20
0.93%
-3.48
After Hours:
371.20
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Waters Corp stock is traded at $371.20, with a volume of 803.76K.
It is down -0.93% in the last 24 hours and down -0.86% over the past month.
Waters sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. In early 2026, Waters merged with BD's life science and diagnostics business, which increased its concentration in diagnostics (versus none now) and discovery-related life science tools.
See More
Previous Close:
$374.68
Open:
$372.69
24h Volume:
803.76K
Relative Volume:
0.79
Market Cap:
$36.45B
Revenue:
$3.77B
Net Income/Loss:
$449.25M
P/E Ratio:
47.25
EPS:
7.8556
Net Cash Flow:
$240.68M
1W Performance:
+3.82%
1M Performance:
-0.86%
6M Performance:
-4.84%
1Y Performance:
+22.53%
1-Day Range:
$367.67
$375.97
1-Week Range:
$345.20
$389.99
52-Week Range:
$275.05
$414.15
Waters Corp Stock (WAT) Company Profile
Name
Waters Corp
Sector
Industry
Phone
(508) 478-2000
Address
34 MAPLE ST, MILFORD, MA
Compare WAT vs TMO, DHR, IDXX, A, NTRA
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
WAT
Waters Corp
|
371.20 | 36.79B | 3.77B | 449.25M | 240.68M | 7.8556 |
TMO
Thermo Fisher Scientific Inc
|
559.53 | 211.18B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
196.50 | 134.62B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
556.20 | 42.94B | 4.45B | 1.10B | 1.06B | 13.59 |
A
Agilent Technologies Inc
|
137.89 | 39.14B | 7.23B | 1.41B | 1.09B | 4.979 |
NTRA
Natera Inc
|
258.03 | 37.52B | 2.50B | -226.32M | 71.51M | -1.6412 |
Waters Corp Stock (WAT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-06-26 | Upgrade | Evercore ISI | In-line → Outperform |
| Feb-10-26 | Resumed | Barclays | Overweight |
| Feb-10-26 | Resumed | Citigroup | Buy |
| Feb-10-26 | Resumed | Evercore ISI | In-line |
| Jan-06-26 | Initiated | Guggenheim | Buy |
| Jan-05-26 | Initiated | William Blair | Outperform |
| Dec-10-25 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Dec-02-25 | Initiated | Morgan Stanley | Equal-Weight |
| Oct-08-25 | Initiated | Rothschild & Co Redburn | Buy |
| Mar-31-25 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Mar-26-25 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Feb-13-25 | Upgrade | Scotiabank | Sector Perform → Sector Outperform |
| Feb-10-25 | Upgrade | Barclays | Underweight → Equal Weight |
| Jan-10-25 | Upgrade | Bernstein | Mkt Perform → Outperform |
| Dec-23-24 | Initiated | Scotiabank | Sector Perform |
| Oct-08-24 | Upgrade | Jefferies | Hold → Buy |
| Aug-28-24 | Initiated | Wells Fargo | Overweight |
| Aug-01-24 | Upgrade | Leerink Partners | Market Perform → Outperform |
| Jun-03-24 | Resumed | Jefferies | Hold |
| Nov-13-23 | Downgrade | Barclays | Equal Weight → Underweight |
| Sep-28-23 | Initiated | Bernstein | Mkt Perform |
| Jul-31-23 | Downgrade | Barclays | Overweight → Equal Weight |
| Jul-31-23 | Downgrade | Evercore ISI | Outperform → In-line |
| Dec-14-22 | Initiated | Deutsche Bank | Hold |
| Aug-25-22 | Initiated | Credit Suisse | Neutral |
| Jul-20-22 | Initiated | UBS | Neutral |
| May-18-22 | Initiated | Barclays | Overweight |
| May-17-22 | Upgrade | BofA Securities | Underperform → Neutral |
| Apr-25-22 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Oct-15-21 | Resumed | Cowen | Market Perform |
| Jul-06-21 | Upgrade | Evercore ISI | In-line → Outperform |
| Jan-07-21 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| Dec-17-20 | Upgrade | Cleveland Research | Underperform → Buy |
| Dec-16-20 | Upgrade | Citigroup | Sell → Neutral |
| Dec-02-20 | Initiated | Goldman | Neutral |
| Nov-10-20 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Jul-28-20 | Upgrade | JP Morgan | Underweight → Neutral |
| Jul-16-20 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Jan-08-20 | Downgrade | Needham | Hold → Underperform |
| Jan-08-20 | Initiated | Wells Fargo | Underweight |
| Jan-07-20 | Initiated | Citigroup | Sell |
| Nov-15-19 | Initiated | Stifel | Hold |
| Oct-09-19 | Downgrade | Barclays | Equal Weight → Underweight |
| Jul-16-19 | Downgrade | BofA/Merrill | Neutral → Underperform |
| Jun-12-19 | Downgrade | Cleveland Research | Neutral → Underperform |
| May-30-19 | Initiated | Wolfe Research | Underperform |
| Jan-24-19 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Jan-03-19 | Upgrade | BofA/Merrill | Underperform → Neutral |
| Jan-03-19 | Initiated | Needham | Hold |
| Dec-12-18 | Downgrade | JP Morgan | Neutral → Underweight |
| Nov-30-18 | Downgrade | Goldman | Neutral → Sell |
| Oct-11-18 | Upgrade | Cleveland Research | Sell → Neutral |
View All
Waters Corp Stock (WAT) Latest News
Waters Launches More Sensitive Mass Spectrometry System for Clinical Laboratories - Clinical Lab Products
Waters Launches Industry's Most Sensitive and Robust Clinical IVD System with Xevo TQ Absolute XR IVD Mass Spectrometer – Company AnnouncementFT.com - Financial Times
Waters Corp (WAT) Income Statement - TradingKey
Waters Corp (WAT) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Waters Corp (WAT) Cash Flow - TradingKey
Waters Corp (WAT) Q4 2022 Earnings ReportResults, Call & Slides - TipRanks
Waters stock trades steadily as recurring instrument demand supports earnings - Ad-hoc-news.de
Waters Corp (WAT) Q2 2023 Earnings ReportResults, Call & Slides - TipRanks
Waters Corp (WAT) Q4 2023 Earnings ReportResults, Call & Slides - TipRanks
Waters Corp (WAT) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Waters Corp (WAT) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Waters Corp (0LTI) Q4 2023 Earnings ReportResults, Call & Slides - TipRanks
Waters Corp. stock underperforms Friday when compared to competitors - MarketWatch
Waters Corp (0LTI) Q3 2024 Earnings ReportResults, Call & Slides - TipRanks
Waters Corp (WAT) Q4 2025 Earnings ReportResults, Call & Slides - TipRanks
Waters Corp (WAT) Q1 2025 Earnings ReportResults, Call & Slides - TipRanks
Waters Corp (WAT) Q4 2024 Earnings ReportResults, Call & Slides - TipRanks
Waters Corp (WAT) Q1 2026 Earnings ReportResults, Call & Slides - TipRanks
Waters Corporation (WAT) stock price, news, quote and history - Yahoo Finance Singapore
Waters Corp (WAT) Q3 2025 Earnings ReportResults, Call & Slides - TipRanks
Waters stock trades steady as recurring revenue and margins support valuation - Ad-hoc-news.de
WAT|Waters Corp|Price:374.680|Chg%:-7.970 - TradingKey
Waters Corp (WAT) Q1 2024 Earnings ReportResults, Call & Slides - TipRanks
Waters Corp (WAT) Q3 2024 Earnings ReportResults, Call & Slides - TipRanks
Waters Corp (WAT) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Waters Corp (WAT) Shares Surge 3.1% -- What GF Score of 94 Tells Investors - GuruFocus
Waters Corp. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch
Waters stock holds firm as investors weigh recent earnings and life sciences demand - Ad-hoc-news.de
Waters Corporation (WAT) Stock Price, News, Quote & History - Yahoo! Finance Canada
Waters Corp. stock outperforms competitors on strong trading day - MarketWatch
Waters Corp. Stock Falls 3.1%, Underperforms Peers - webull.com
Waters stock trades steadily as recurring revenue grows and margins expand - Ad-hoc-news.de
A Look at Waters Corp (WAT) After 3.1% Decline -- GF Value $429. - GuruFocus
Waters Corp. stock underperforms Monday when compared to competitors - MarketWatch
Waters stock trades steady as chromatography and mass spectrometry demand supports earnings outlook - Ad-hoc-news.de
Waters stock trades steadily as recurring revenue and margins underpin valuation - Ad-hoc-news.de
Waters stock trades steadily as recurring revenue and margins support valuation - Ad-hoc-news.de
Q1 Research Tools & Consumables Earnings Review: First Prize Goes to Waters Corporation (NYSE:WAT) - Yahoo Finance
Mass Spectrometry Market Size Worth USD 14.09 Billion by 2035 | SNS Insider - GlobeNewswire Inc.
Waters stock trades steadily as chromatography demand supports revenue growth - AD HOC NEWS
WATERS CORP : TD COWEN RAISES TARGET PRICE TO $408 FROM $385 - Moomoo
What Just Happened with BD and Waters - Kavout | AI
Waters Corporation's Quarterly Earnings Preview: What You Need to Know - inkl
Waters Corp stock holds steady as analytical instruments underpin long-term demand - Ad-hoc-news.de
The Bull Case For Waters (WAT) Could Change Following Removal From Key Russell Indices Learn Why - simplywall.st
Waters Corporation (WAT) Gains as RBC Initiates Coverage with Ou - GuruFocus
Waters Corp. Coin Cell DSC: Direct Thermal and Gas Analysis for Battery SafetyNews and Statistics - IndexBox
RBC Capital initiates Waters stock coverage with outperform rating By Investing.com - Investing.com Nigeria
RBC Capital initiates Waters stock coverage with outperform rating - Investing.com
Waters Corp : RBC Initiates Coverage With Out - Moomoo
Waters Corporation outlines its role in analytical science as investors watch long-term growth drive - ad-hoc-news.de
Waters Corp Stock (WAT) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.51%
2.48%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):